يعرض 201 - 220 نتائج من 66,621 نتيجة بحث عن '(( 5 we decrease ) OR ((( 50 ((ms decrease) OR (mean decrease)) ) OR ( 5 a decrease ))))', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 201

    Data sources for calibration and evaluation. حسب Yonghui Zhang (279832)

    منشور في 2024
    "…Root means square error (RMSE) (mean absolute error (MAE), coefficient of determination (R<sup>2</sup>), and Nash Sutcliffe model efficiency (NSE)) are 15.50 (14.63, 0.96, 0.42), 4.76 (3.92, 0.97, 0.95), 4.69 (3.72, 0.98, 0.95), 3.91 (3.40, 0.99, 0.96) and 12.54 (11.67, 0.95, 0.60), 5.07 (4.61, 0.98, 0.93), 4.97 (4.28, 0.97, 0.94), 4.58 (4.02, 0.98, 0.95) for using one, two, three, and four observed phenological stages in the CSPs estimation. …"
  2. 202
  3. 203

    Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  4. 204

    Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  5. 205

    Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  6. 206

    Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  7. 207

    Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  8. 208

    Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  9. 209

    Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx حسب Mohammad Arif Rahman (8267352)

    منشور في 2024
    "…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …"
  10. 210
  11. 211

    Fig 5 - حسب Felix Bosch (10024550)

    منشور في 2021
  12. 212
  13. 213
  14. 214
  15. 215
  16. 216

    S1 Fig - حسب Pierre Bauvin (18154818)

    منشور في 2024
  17. 217

    Flowchart of patients. حسب Seydou Goro (17847203)

    منشور في 2024
    "…Mortality at 30 days was 3.6% and we found that the mortality decreases with increasing of the hospital activity. …"
  18. 218
  19. 219
  20. 220